• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Large owner Hill Path Capital Partners Co-Investment S Lp was granted 1,980 shares (SEC Form 4)

    7/2/25 4:16:18 PM ET
    $PRKS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Get the next $PRKS alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Hill Path Capital Partners Co-Investment S LP

    (Last) (First) (Middle)
    150 EAST 58TH STREET
    33RD FLOOR

    (Street)
    NEW YORK NY 10155

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    United Parks & Resorts Inc. [ PRKS ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    06/30/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    Form filed by One Reporting Person
    X Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock(1)(2) 06/30/2025 A 1,980(3) A $47.33 90,925 I By Scott Ross
    Common Stock(1)(2) 5,885,065 I By Hill Path Capital Partners LP(4)
    Common Stock(1)(2) 176,201 I By Hill Path Capital Co-Investment Partners LP(5)
    Common Stock(1)(2) 6,109,961 I By Hill Path Capital Partners Co-Investment E LP(6)
    Common Stock(1)(2) 402,017 I By Hill Path Capital Partners Co-Investment E2 LP(7)
    Common Stock(1)(2) 1,334,162 I By Hill Path Capital Partners-H LP(8)
    Common Stock(1)(2) 83,900 I By Hill Path Capital Partners Co-Investment S LP(9)
    Common Stock(1)(2) 10,518,006 I By HEP Fund LP(10)
    Common Stock(1)(2) 2,695,994 I By HM Fund LP(11)
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    1. Name and Address of Reporting Person*
    Hill Path Capital Partners Co-Investment S LP

    (Last) (First) (Middle)
    150 EAST 58TH STREET
    33RD FLOOR

    (Street)
    NEW YORK NY 10155

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    Hill Path Capital Partners S GP LLC

    (Last) (First) (Middle)
    150 EAST 58TH STREET
    33RD FLOOR

    (Street)
    NEW YORK NY 10155

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    Hill Path Holdings LLC

    (Last) (First) (Middle)
    150 EAST 58TH STREET
    33RD FLOOR

    (Street)
    NEW YORK NY 10155

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    HEP FUND LP

    (Last) (First) (Middle)
    150 EAST 58TH STREET
    33RD FLOOR

    (Street)
    NEW YORK NY 10155

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    HM FUND LP

    (Last) (First) (Middle)
    150 EAST 58TH STREET
    33RD FLOOR

    (Street)
    NEW YORK NY 10155

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    HE GP LLC

    (Last) (First) (Middle)
    150 EAST 58TH STREET
    33RD FLOOR

    (Street)
    NEW YORK NY 10155

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    HM GP LLC

    (Last) (First) (Middle)
    150 EAST 58TH STREET
    33RD FLOOR

    (Street)
    NEW YORK NY 10155

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    Explanation of Responses:
    1. This Form 4 is filed jointly by Hill Path Capital Partners LP ("Hill Path Capital"), Hill Path Co-Investment Partners LP ("Hill Path Co-Investment"), Hill Path Capital Partners-H LP ("Hill Path H"), Hill Path Capital Partners Co-Investment E LP ("Hill Path E"), Hill Path Capital Partners Co-Investment E2 LP ("Hill Path E2"), Hill Path Capital Partners Co-Investment S LP ("Hill Path S"), HEP Fund LP ("HEP Fund"), HM Fund LP ("HM Fund"), Hill Path Capital Partners GP LLC ("Hill Path GP"), Hill Path Capital Partners E GP LLC ("Hill Path E GP"), Hill Path Capital Partners S GP LLC ("Hill Path S GP"), HE GP LLC ("HE GP"), HM GP LLC ("HM GP"), Hill Path Investment Holdings LLC ("Hill Path Investment Holdings"), Hill Path Capital LP ("Hill Path"), Hill Path Holdings LLC ("Hill Path Holdings") and Scott Ross ("Mr. Ross," and collectively with the aforementioned entities, the "Reporting Persons").
    2. To enable all of the Reporting Persons to gain access to the Securities and Exchange Commission's electronic filing system (which only accepts a maximum of 10 joint filers per report), this report is the second of two identical reports relating to the same transactions being filed with the Securities and Exchange Commission. Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group along with HAT Fund LP and HAT Fund II LP, which do not beneficially own any shares of Common Stock, that collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Mr. Ross is also a director of the Issuer. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
    3. Granted under the Issuer's 2017 Omnibus Incentive Plan and vests 100% immediately.
    4. Shares of Common Stock owned directly by Hill Path Capital. Hill Path GP, as the general partner of Hill Path Capital, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path Capital. Hill Path Investment Holdings, as the managing member of Hill Path GP, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path Capital. Hill Path, as the investment manager of Hill Path Capital, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path Capital. Hill Path Holdings, as the general partner of Hill Path, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path Capital. Mr. Ross, as the managing partner of each of Hill Path Investment Holdings, Hill Path and Hill Path Holdings, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path Capital.
    5. Shares of Common Stock owned directly by Hill Path Co-Investment. Hill Path GP, as the general partner of Hill Path Co-Investment, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path Co-Investment. Hill Path Investment Holdings, as the managing member of Hill Path GP, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path Co-Investment. Hill Path, as the investment manager of Hill Path Co-Investment, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path Co-Investment. Hill Path Holdings, as the general partner of Hill Path, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path Co-Investment. Mr. Ross, as the managing partner of each of Hill Path Investment Holdings, Hill Path and Hill Path Holdings, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path Co-Investment.
    6. Shares of Common Stock owned directly by Hill Path E. Hill Path E GP, as the general partner of Hill Path E, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path E. Hill Path Investment Holdings, as the managing member of Hill Path E GP, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path E. Hill Path, as the investment manager of Hill Path E, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path E. Hill Path Holdings, as the general partner of Hill Path, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path E. Mr. Ross, as the managing partner of each of Hill Path Investment Holdings, Hill Path and Hill Path Holdings, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path E.
    7. Shares of Common Stock owned directly by Hill Path E2. Hill Path E GP, as the general partner of Hill Path E2, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path E2. Hill Path Investment Holdings, as the managing member of Hill Path E GP, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path E2. Hill Path, as the investment manager of Hill Path E2, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path E2. Hill Path Holdings, as the general partner of Hill Path, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path E2. Mr. Ross, as the managing partner of each of Hill Path Investment Holdings, Hill Path and Hill Path Holdings, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path E2.
    8. Shares of Common Stock owned directly by Hill Path H. Hill Path GP, as the general partner of Hill Path H, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path H. Hill Path Investment Holdings, as the managing member of Hill Path GP, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path H. Hill Path, as the investment manager of Hill Path H, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path H. Hill Path Holdings, as the general partner of Hill Path, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path H. Mr. Ross, as the managing partner of each of Hill Path Investment Holdings, Hill Path and Hill Path Holdings, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path H.
    9. Shares of Common Stock owned directly by Hill Path S. Hill Path S GP, as the general partner of Hill Path S, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path S. Hill Path Investment Holdings, as the managing member of Hill Path S GP, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path S. Hill Path, as the investment manager of Hill Path S, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path S. Hill Path Holdings, as the general partner of Hill Path, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path S. Mr. Ross, as the managing partner of each of Hill Path Investment Holdings, Hill Path and Hill Path Holdings, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path S.
    10. Shares of Common Stock owned directly by HEP Fund. HE GP, as the general partner of HEP Fund, may be deemed to beneficially own the shares of Common Stock owned directly by HEP Fund. Hill Path Investment Holdings, as the managing member of HE GP, may be deemed to beneficially own the shares of Common Stock owned directly by HEP Fund. Hill Path, as the investment manager of HEP Fund, may be deemed to beneficially own the shares of Common Stock owned directly by HEP Fund. Hill Path Holdings, as the general partner of Hill Path, may be deemed to beneficially own the shares of Common Stock owned directly by HEP Fund. Mr. Ross, as the managing member of each of Hill Path Investment Holdings, Hill Path and Hill Path Holdings, may be deemed to beneficially own the shares of Common Stock owned directly by HEP Fund.
    11. Shares of Common Stock owned directly by HM Fund. HM GP, as the general partner of HM Fund, may be deemed to beneficially own the shares of Common Stock owned directly by HM Fund. Hill Path Investment Holdings, as the managing member of HM GP, may be deemed to beneficially own the shares of Common Stock owned directly by HM Fund. Hill Path, as the investment manager of HM Fund, may be deemed to beneficially own the shares of Common Stock owned directly by HM Fund. Hill Path Holdings, as the general partner of Hill Path, may be deemed to beneficially own the shares of Common Stock owned directly by HM Fund. Mr. Ross, as the managing member of each of Hill Path Investment Holdings, Hill Path and Hill Path Holdings, may be deemed to beneficially own the shares of Common Stock owned directly by HM Fund.
    Hill Path Capital Partners Co-Investment S LP, By: Hill Path Capital Partners S GP LLC, By: /s/ Scott Ross, Managing Partner 07/02/2025
    Hill Path Capital Partners S GP LLC, By: Hill Path Investment Holdings LLC, By: /s/ Scott Ross, Managing Partner 07/02/2025
    Hill Path Holdings LLC, By: /s/ Scott Ross, Managing Partner 07/02/2025
    HEP Fund LP, By: HE GP LLC, By: /s/ Scott Ross, Managing Partner 07/02/2025
    HM Fund LP, By: HM GP LLC, By: /s/ Scott Ross, Managing Partner 07/02/2025
    HE GP LLC, By: Hill Path Investment Holdings LLC, By: /s/ Scott Ross, Managing Partner 07/02/2025
    HM GP LLC, By: Hill Path Investment Holdings LLC, By: /s/ Scott Ross, Managing Partner 07/02/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $PRKS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $PRKS

    DatePrice TargetRatingAnalyst
    3/14/2025$50.00Equal Weight
    Barclays
    8/8/2024$63.00 → $53.00Buy → Neutral
    Goldman
    4/4/2024$73.00Buy
    Guggenheim
    3/26/2024$47.00Underperform
    Mizuho
    More analyst ratings

    $PRKS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Officer Mikolaichik James bought $1,947,860 worth of shares (34,000 units at $57.29), increasing direct ownership by 80% to 76,267 units (SEC Form 4)

      4 - United Parks & Resorts Inc. (0001564902) (Issuer)

      11/25/24 4:10:18 PM ET
      $PRKS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $PRKS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Hill Path Capital Partners Co-Investment S Lp was granted 1,980 shares (SEC Form 4)

      4 - United Parks & Resorts Inc. (0001564902) (Issuer)

      7/2/25 4:16:18 PM ET
      $PRKS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Large owner Hill Path Capital Partners Lp was granted 1,980 shares (SEC Form 4)

      4 - United Parks & Resorts Inc. (0001564902) (Issuer)

      7/2/25 4:15:35 PM ET
      $PRKS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Director Dalal Aayushi was granted 108 shares, increasing direct ownership by 2% to 5,466 units (SEC Form 4)

      4 - United Parks & Resorts Inc. (0001564902) (Issuer)

      7/2/25 4:14:40 PM ET
      $PRKS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $PRKS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Barclays initiated coverage on United Parks & Resorts Inc. with a new price target

      Barclays initiated coverage of United Parks & Resorts Inc. with a rating of Equal Weight and set a new price target of $50.00

      3/14/25 7:39:46 AM ET
      $PRKS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • United Parks & Resorts Inc. downgraded by Goldman with a new price target

      Goldman downgraded United Parks & Resorts Inc. from Buy to Neutral and set a new price target of $53.00 from $63.00 previously

      8/8/24 6:48:33 AM ET
      $PRKS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Guggenheim initiated coverage on United Parks & Resorts Inc. with a new price target

      Guggenheim initiated coverage of United Parks & Resorts Inc. with a rating of Buy and set a new price target of $73.00

      4/4/24 8:11:55 AM ET
      $PRKS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $PRKS
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • In Celebration of July 4th, Busch Gardens is Proud to Honor Veterans and Active-Duty Military with FREE Tickets as a Thank You for their Service

      Active-duty military and Veterans plus their guests are invited to visit the parks for FREE ORLANDO, Fla., June 13, 2025 /PRNewswire/ -- In advance of Independence Day, Busch Gardens parks in Tampa Bay and Williamsburg as well as Adventure Island and Water Country USA are proudly honoring the bravery and sacrifice of all U.S. military active-duty and veterans and their families to enjoy a day at the parks for FREE. It's Busch Gardens' way of saying thank you – and giving America's heroes the chance to create unforgettable memories with the people they love. U.S. military veter

      6/13/25 12:43:00 PM ET
      $PRKS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • In Celebration of July 4th, SeaWorld is Proud to Honor Veterans and Active-Duty Military with FREE Tickets as a Thank You for their Service

      Active-duty military and Veterans plus their guests are invited to visit the parks for FREE ORLANDO, Fla., June 13, 2025 /PRNewswire/ -- In advance of Independence Day, all SeaWorld parks in Orlando, San Antonio and San Diego as well as Aquatica parks in Orlando and San Antonio, are proudly honoring the bravery and sacrifice of all U.S. military active-duty and veterans and their families to enjoy a day at the parks for FREE. It's SeaWorld's way of saying thank you – and giving America's heroes the chance to create unforgettable memories with the people they love. For more tha

      6/13/25 12:18:00 PM ET
      $PRKS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Meet the Emperors: SeaWorld Orlando Introduces Western Hemisphere's Only Emperor Penguins

      The world's largest and most iconic penguin species makes its exclusive debut at SeaWorld Orlando DOWNLOAD MEDIA ASSETS HERE ORLANDO, Fla., June 9, 2025 /PRNewswire/ -- SeaWorld Orlando is making history this summer as the only place in the Western Hemisphere where guests can see Emperor penguins—the world's largest and most iconic penguin species – up close. Beginning June 14, guests will be able to witness these iconic Antarctic animals up close in the park's Antarctica Realm. SeaWorld Orlando will be the only place in the Western Hemisphere where the public can see Emperor penguins.

      6/9/25 10:00:00 AM ET
      $PRKS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $PRKS
    SEC Filings

    See more
    • United Parks & Resorts Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - United Parks & Resorts Inc. (0001564902) (Filer)

      6/17/25 4:33:37 PM ET
      $PRKS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form DEFA14A filed by United Parks & Resorts Inc.

      DEFA14A - United Parks & Resorts Inc. (0001564902) (Filer)

      6/6/25 4:24:51 PM ET
      $PRKS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form SD filed by United Parks & Resorts Inc.

      SD - United Parks & Resorts Inc. (0001564902) (Filer)

      5/30/25 4:19:21 PM ET
      $PRKS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $PRKS
    Leadership Updates

    Live Leadership Updates

    See more
    • The Legacy Continues: North America's Longest Inverted Family Coaster Opens at Busch Gardens Williamsburg on May 23 with the Return of the Big Bad Wolf

      Members will be among the first to ride beginning May 16 during the park's monumental 50thAnniversary Celebration festivities, including a special lookback presentation, 1970s music, fireworks and more DOWNLOAD MEDIA ASSETS HERE WILLIAMSBURG, Va., May 1, 2025 /PRNewswire/ -- Hear the howl as The Big Bad Wolf: The Wolf's Revenge, Busch Gardens Williamsburg's newest and most immersive family attraction is unleashed on May 23 as North America's longest family inverted coaster. Members will be among the first to ride starting on May 16 during the park's 50th anniversary celebration. Members will also get additional exclusive ride times on May 17 and 18.

      5/1/25 1:00:00 PM ET
      $PRKS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SeaWorld Orlando Reaches Historic Milestone with 1,000th Manatee Rescue, Reinforcing Decades of Dedication to Animal Rescue, Rehabilitation and Return

      DOWNLOAD MEDIA ASSETS HERE ORLANDO, Fla., March 26, 2025 /PRNewswire/ -- SeaWorld Orlando has reached a historic milestone – 1,000 manatee rescues – marking a significant step in the ongoing fight to protect this vulnerable species. This achievement highlights SeaWorld's leadership in marine conservation, reinforcing its critical role in rescue, rehabilitation and return efforts. SeaWorld Orlando has spent nearly five decades committed to marine wildlife conservation and rescue. Since 1976, SeaWorld Orlando's dedicated rescue team has operated one of only three critical care f

      3/26/25 8:00:00 AM ET
      $PRKS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Five Manatees Successfully Rehabilitated at Two Ohio Zoos Flown Back to Florida Facilities to Prepare for Return to Home Waters

      ORLANDO, Fla., Oct. 15, 2024 /PRNewswire/ -- Five manatees were flown more than 1,000 miles to their temporary homes in Florida, marking a crucial conservation achievement following over two years of successful rescue efforts by four zoological and marine institutions. In an intricate operation, the manatees were placed in custom-built containers to help them travel safely and then driven to the Cincinnati International Airport at the DHL Express Global hub. All of the manatees were loaded onto a specially scheduled DHL cargo plane to head to Florida, where they will complete

      10/15/24 10:00:00 AM ET
      $PRKS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $PRKS
    Financials

    Live finance-specific insights

    See more
    • United Parks & Resorts Inc. Reports First Quarter 2025 Results

      ORLANDO, Fla., May 12, 2025 /PRNewswire/ -- United Parks & Resorts Inc. (NYSE:PRKS), a leading theme park and entertainment company, today reported its financial results for the first quarter of 2025. First Quarter 2025 Highlights Attendance was 3.4 million guests, a decrease of approximately 59,000 guests or 1.7% from the first quarter of 2024.Total revenue was $286.9 million, a decrease of $10.5 million or 3.5% from the first quarter of 2024.Net loss was $16.1 million, a decrease of $4.9 million from the first quarter of 2024.Adjusted EBITDA[1] was $67.4 million, a decrease

      5/12/25 6:30:00 AM ET
      $PRKS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • UNITED PARKS & RESORTS INC. ANNOUNCES FIRST QUARTER EARNINGS RELEASE DATE AND CONFERENCE CALL INFORMATION

      ORLANDO, Fla., April 30, 2025 /PRNewswire/ -- United Parks & Resorts Inc. (NYSE:PRKS) announced today that it will release its first quarter financial results before the market opens on Monday, May 12, 2025. In conjunction with the release, the Company has scheduled a conference call, which will be broadcast live over the internet on Monday, May 12, 2025, at 9 a.m. Eastern Time. The release and the conference call can be accessed via the Company's website at www.UnitedParksInvestors.com. For those unable to participate in the live webcast, a replay will be available beginning at approximately 12 p.m. Eastern Time on May 12, 2025, under the "Events & Presentations" tab of www.UnitedParksInves

      4/30/25 4:05:00 PM ET
      $PRKS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • United Parks & Resorts Inc. Reports Fourth Quarter and Fiscal 2024 Results

      ORLANDO, Fla., Feb. 26, 2025 /PRNewswire/ -- United Parks & Resorts Inc. (NYSE:PRKS), a leading theme park and entertainment company, today reported its financial results for the fourth quarter and fiscal year 2024. Fourth Quarter 2024 Highlights Attendance was 4.9 million guests, a decrease of approximately 79,000 guests from the fourth quarter of 2023.Total revenue was $384.4 million, a decrease of $4.6 million or 1.2% from the fourth quarter of 2023.Net income was $27.9 million, a decrease of $12.2 million from the fourth quarter of 2023.Adjusted EBITDA[1] was $144.5 million a decrease of $6.0 million from the fourth quarter of 2023.Total revenue per capita[2] increased 0.4% to $78.75 fro

      2/26/25 6:30:00 AM ET
      $PRKS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $PRKS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by United Parks & Resorts Inc.

      SC 13D/A - United Parks & Resorts Inc. (0001564902) (Subject)

      11/13/24 5:20:01 PM ET
      $PRKS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form SC 13G filed by United Parks & Resorts Inc.

      SC 13G - United Parks & Resorts Inc. (0001564902) (Subject)

      11/13/24 4:16:58 PM ET
      $PRKS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Amendment: SEC Form SC 13D/A filed by United Parks & Resorts Inc.

      SC 13D/A - United Parks & Resorts Inc. (0001564902) (Subject)

      8/12/24 7:01:08 PM ET
      $PRKS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care